Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.
Several genome-wide association studies (GWAS) have been conducted to identify the common single nucleotide polymorphisms (SNPs) that influence the risk of prostate cancer. It was hypothesized that some prostate cancer-associated SNPs might relate to the clinical outcomes in patients treated for pro...
Main Authors: | Shu-Pin Huang, Bo-Ying Bao, Tzyh-Chyuan Hour, Chao-Yuan Huang, Chia-Cheng Yu, Chia-Chu Liu, Yung-Chin Lee, Chun-Nung Huang, Jiunn-Bey Pao, Chun-Hsiung Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3402522?pdf=render |
Similar Items
-
Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer.
by: Chia-Cheng Yu, et al.
Published: (2013-01-01) -
Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan
by: Kuang-Ming Liao, et al.
Published: (2019-12-01) -
Plasma biomarkers and their correlation in adult children of parents with Alzheimer’s disease
by: Ling-Chun Huang, et al.
Published: (2022-08-01) -
Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder.
by: Shiu-Dong Chung, et al.
Published: (2017-01-01) -
Impact of the CYP2D6 single nucleotide polymorphism on the concentration of and therapeutic response to donepezil in mild-to-moderate Alzheimer's disease
by: Ping-Song Chou, et al.
Published: (2022-01-01)